SPP1 and metabolic dysfunction-associated steatotic liver disease: SPP1 is upregulated in obesity and several models of liver injury (29, 30).Studies have demonstrated a pivotal role of SPP1 in obesity-driven nutrition-dependent diseases, including NAFLD, suggesting SPP1 as a treatment target (13, 31).